Exhibit
99.1

Odysight.ai
Reports Financial Results for the Nine Months Ended September 30, 2026, and Provides Business Update
| ■ |
Revenues:
$0.9 million for the first nine months, with fourth-quarter revenues expected to increase compared to the third quarter
based on current delivery schedules with customers. |
| |
|
| ■ |
Backlog:
$16 million as of September 30, 2026, not yet reflecting a number of fleet-level proposals under negotiation with key customers. |
| |
|
| ■ |
Cash
position: approximately $23.2 million and no financial debt, with approximately $1.2 million collected since quarter end,
and runway the Company believes will be sufficient, assuming pipeline conversion, to fund its operations into the second quarter
of 2028. |
| |
|
| ■ |
Commercial
milestones: Over the next 12 months, we aim to complete the current phases of our agreements with several key customers, each
structured to create a pathway to broader deployments, while advancing the conversion of our fleet-level proposals under negotiation
into signed agreements. |
Ramat
Gan, Israel, November 16, 2026 – Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive
maintenance (PdM) solutions for the aerospace, defense, and industrial markets, today announces its financial results for the nine months
ended September 30, 2026, and provides a business update.
Key
Highlights
Revenues
of $0.9 million for the nine months ended September 30, 2026; when focusing on the aerospace domain, up 29% compared to revenue in
this domain last year. Based on current delivery schedules agreed with our customers, the Company expects to deliver orders from our
existing backlog to five customers in the fourth quarter of 2026 and, as a result, we expect revenues for the fourth quarter of 2026
to increase compared to the third quarter of 2026.
Backlog1
of $16 million as of September 30, 2026; our current backlog does not yet reflect a number of fleet-level proposals currently under
negotiation with key customers. We believe these opportunities have the potential to substantially grow our backlog in the near term.
Cash
balance2 of approximately $23.2 million as of September 30, 2026, with no financial debt; in August
2026 we completed a public offering with participation from our chairman, other members of our board of directors and existing shareholders,
strengthening our balance sheet as we accelerate our business. We continue to maintain strict cost discipline and see consistent collections
from customers, both in Israel and internationally. Since the end of the third quarter, we have collected approximately $1.2 million
from some of our key customers.
Based
on our current cash balance, our existing backlog and our current forecast and operating plan, which assumes the conversion of
certain opportunities in our pipeline into signed agreements, we believe our existing resources will be sufficient to fund our operations
into the second quarter of 2028. This estimate is subject to a number of assumptions and uncertainties, including the timing and completion
of negotiations with customers, the signing of new agreements, the timing of deliveries and collections, and exchange rate fluctuations,
any of which could cause our actual cash needs to differ materially; in addition, we could use our available resources sooner
than we currently expect.
Commercial
Highlights
| |
● |
Major
defense customer (January), two pilot orders – one for monitoring of a critical component within an airborne weapons system,
which has been fully delivered, and a second for an operational combat helicopter, which is at an advanced stage of the delivery
process. |
| |
● |
XP
Services U.S. Partnership for UH-60 Black Hawk test flights (March) – completed test flights in June and continued with
active flight operations, demonstrating system monitoring capabilities for defined use cases and began presenting the solution to
potential U.S. customers. |
| |
● |
Naval
Air Warfare Center Aircraft Division (NAWCAD) Lakehurst, part of the U.S. Navy (May), Cooperative Research and Development Agreement
(CRADA), focusing initially on carrier arresting cables. The project is under delivery. Once completed, it has the potential for
expansion into global land-based arresting cables, fixed- and rotary-wing aircraft, ground vehicles, and additional platforms. |
| |
● |
Honeywell
Aerospace (June), advanced the proof-of-concept collaboration with the APU Division across its Auxiliary Power Units (APU) portfolio,
initially focused on the APU air intake. Milestones are under delivery. |
| |
● |
Elbit
Systems on behalf of the Israeli Ministry of Defense (IMOD) (July), purchase order for integration into several platforms, with
delivery milestones underway. |
| |
● |
Signed
a Memorandum of Agreement (MOA) with Boeing (August) to demonstrate our solutions in laboratory and test environments at two
Boeing sites with delivery milestones in progress. |
| |
● |
NTA
Metropolitan Mass Transit System Ltd. (November), launched a new pilot on the Tel Aviv Light Rail Red Line, with our technology
installed to monitor critical railway switches. This is another industrial deployment of our solution in a rail application. Beyond
this pilot, we see significant potential for broader deployment across railway networks and infrastructures at large, creating new
opportunities for commercial growth while making critical infrastructure safer, more reliable, and more efficient. |
Yehu
Ofer, Chief Executive Officer:
“The
third quarter was about execution: working closely with our key customers to convert our pipeline into orders and deliveries. Our MOA
with Boeing and agreements with Honeywell Aerospace, the Israeli Ministry of Defense and the U.S. Navy are each rooted in proven technology
solutions across platforms. Each is structured to create a pathway to broader deployment upon successful completion of the current phase,
with the potential to expand across multiple portfolios. In addition, our current backlog does not yet reflect a number of fleet-level
proposals currently under negotiation with key customers, which we believe have the potential to substantially grow our backlog in the
near term. We are continuing to strengthen our technological capabilities while accelerating deliveries, expanding globally and converting
opportunities into measurable results, all with a disciplined approach to every dollar we spend. Our focus remains on creating lasting
value for our customers and shareholders.”
Einav
Brenner, Chief Financial Officer:
“Revenues
for the first nine months of 2026 were $0.9 million, substantially all from the aerospace domain, with aerospace revenues
up 29% compared to the same period last year. As previously communicated, revenues are weighted towards the end of the year as
deliveries are in process based on customers’ schedules. Backlog stood at $16 million as of September 30, 2026, and we are focused
on converting our pipeline into orders in the coming quarters.
Operating
expenses for the first nine months of 2026 were approximately $14.6 million, compared to $14.4 million in the same period last year,
reflecting investment in global business development, marketing and sales required to support our growth. In parallel, we implemented
efficiency measures, including the integration of AI tools and refinements to our workforce and subcontractors structure. Though the
resulting savings were substantially offset by a significant negative USD/NIS exchange rate impact, we intend to continue maintaining
our focus on efficiency as we accelerate our business.
We
ended the quarter with approximately $23.2 million in cash and no financial debt, following the underwritten public offering of
$11 million in gross proceeds completed in August, with participation of our chairman, other members of our board of directors and existing
shareholders. We greatly value this support and the confidence it reflects. This strengthens our balance sheet, and we
believe this gives us the resources to deliver on our backlog and pursue the conversion of larger opportunities in our pipeline
into signed agreements and revenues. We continue to maintain disciplined cost and cash management while focusing our efforts on
accelerating our business over the short and medium term.”
1
Backlog is measured and defined differently by companies within our industry. We refer
to “backlog” as our booked orders based on purchase orders or hard commitments
but not yet recognized as revenue. Backlog is not a comprehensive indicator of future revenue
and is not a measure of profitability. Orders included in backlog may be cancelled or rescheduled
by customers. A variety of conditions, both specific to the individual customer and generally
affecting the customer’s industry, may cause customers to cancel, reduce or delay orders
that were previously made or anticipated. Projects may remain in backlog for extended periods
of time.
2
Including cash, cash equivalents and restricted deposit.
Financial
highlights for the nine months ended September 30, 2026
Revenues
were $0.9 million, compared to $2.6 million for the nine months ended September 30, 2025. The decrease in revenues was fully attributable
to $1.9 million revenues recognized in the first quarter of 2025 from a Fortune 500 medical customer, of which $1.7 million
resulted from the full derecognition of a contract liability, a non-recurring item.
Revenues
for the first nine months of $0.9 million are primarily attributable to the aerospace domain and are up 29% compared to $0.7 million
for the nine months ended September 30, 2025 in the same domain.
Backlog1
was $16 million as of September 30, 2026.
Cost
of Revenues was $0.6 million for the nine months ended September 30, 2026, compared to $1.9 million for the nine months ended
September 30, 2025. In the nine months ended September 30, 2025 we had additional costs of approximately $1.4 million related to
the medical domain.
Cost
of revenues for the first nine months of 2026 of $0.6 million is primarily attributable to the aerospace domain, compared to
$0.5 million for the nine months ended September 30, 2025 in the same domain.
Gross
Profit was $0.4 million for the nine months ended September 30, 2026, compared to gross profit of $0.7 million for the nine months
ended September 30, 2025. In the nine months ended September 30, 2025, we had additional profit of approximately $0.5 million
related to the medical domain.
Gross
profit for the first nine months of 2026 of $0.4 million is primarily attributable to the aerospace domain, compared to
$0.2 million for the nine months ended September 30, 2025 in the same domain.
Gross
Margin was approximately 40% for the nine months ended September 30, 2026, compared to approximately 27% for the nine months
ended September 30, 2025.
Gross
margin for the first nine months of 2026 was approximately 40% and is primarily attributable to the aerospace domain, compared to approximately
34% for the nine months ended September 30, 2025 in the same domain.
Operating
expenses were approximately $14.6 million for the nine months ended September 30, 2026, compared to approximately $14.4 million
for the nine months ended September 30, 2025.
The
increase was primarily driven by investments in global expansion and sales and marketing activities, as well as costs related to supply
chain diversification, and one-time aerospace and cyber certification costs, partially offset by a decrease in stock-based compensation
from approximately $2.6 million to approximately $1.8 million. During the period, we implemented efficiency measures, including the adoption
of AI tools and refinements to our workforce and subcontractors structure. The resulting reductions were substantially offset by the
adverse impact of the USD/NIS exchange rate.
Net
loss was approximately $13.7 million for the nine months ended September 30, 2026, compared to approximately $12.8 million for
the nine months ended September 30, 2025.
Cash
Balance2 as of September 30, 2026 was approximately $23.2 million. No financial debt.
In
August 2026, the Company completed a U.S. underwritten public offering of $11 million in gross proceeds, with participation of
our chairman, other members of our board of directors and existing shareholders.
About
Odysight.ai
Odysight.ai,
incorporated in Nevada U.S., with European and Israeli subsidiaries, is pioneering the Predictive Maintenance (PdM) and Condition Based
Monitoring (CBM) markets with its visualization and AI-powered visual sensing. Providing video sensor-based solutions for critical systems
in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical
industry. Odysight.ai’s unique video-based sensors, embedded software, and AI algorithms are being deployed in hard-to-reach locations
and harsh environments across a variety of PdM and CBM use cases. Odysight.ai’s platform allows maintenance and operations teams
visibility into areas that are otherwise inaccessible during normal operation, or where the operating ambience is not suitable for continuous
real-time monitoring.
We
routinely post information that may be important to investors in the Investors section of our website. For more information, please visit:
http://www.odysight.ai or follow us on X (formerly Twitter) , LinkedIn and YouTube.
Backlog
We
present our results of operations in a way that we believe will be the most meaningful and useful to investors, analysts, rating agencies
and others who use our financial information to evaluate our performance. Backlog is presented for supplemental informational purposes
only, and is not intended to be a substitute for any GAAP financial measures, including revenue or net income (loss), and, as calculated,
may not be comparable to companies in other industries or within the same industry with similarly titled measures of performance. In
addition, backlog should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
Therefore, backlog should be considered in addition to, not as a substitute for, or in isolation from, measures prepared in accordance
with GAAP.
Forward-Looking
Statements
Information
set forth in this news release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 relating to future events or our future performance. All statements contained in this press release that
do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, expectations
regarding monetization and revenue recognition of backlog, the timing of deliveries and expected increase in revenues in the fourth quarter
of 2026, expected cash runway, the potential conversion of proposals under negotiation into orders and growth of our backlog, the potential
for broader deployment of our solutions following current projects, programs, collaborations and agreements, the expected impact of our
efficiency measures and foreign currency exchange rates, and improvements in financial performance, as well as statements regarding long-term
growth prospects. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,”
“expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,”
“potential” or “continue” or the negative of these terms or other comparable terminology. Those statements are
based on information we have when those statements are made or our management’s current expectation and are subject to risks and
uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking
statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to the following:
(i) our ability to scale up our operations, including market acceptance and large-scale adoption of our vision-based sensor products,
(ii) the amount and timing of future sales and our long and unpredictable sales cycles, (iii) our ability to maintain product quality
and performance at an acceptable cost and meet technical and quality specifications, (iv) our ability to accurately estimate the future
supply and demand for our solutions and changes to various factors in our supply chain, (v) the market for adoption of vision-based sensor
technologies, (vi) compliance with existing laws and regulations and regulatory developments in the United States, Israel, and other
jurisdictions, including trade control laws, export authorizations and safety regulations, (vii) our plans and ability to obtain, maintain,
and protect intellectual property rights, including extensions of patent terms, and our ability to avoid infringing the intellectual
property rights of others, (viii) the need to hire additional personnel and our ability to attract and retain such personnel, including
key members of our senior management, (ix) our estimates regarding expenses, backlog, future revenue, capital requirements and need for
additional financing, (x) our dependence on third parties, including suppliers and strategic partners, (xi) our dependence on a limited
number of customers for a substantial portion of our revenues, and the impact if order volumes from existing or anticipated customers
do not meet expectations, (xii) our financial performance and history of operating losses, (xiii) the growth of regulatory requirements
and incentives, (xiv) the incorporation of artificial intelligence, or AI, and machine learning, or ML, into our products, (xv) risks
related to product liability claims or product recalls, (xvi) cybersecurity risks and potential data security breaches, (xvii) the overall
global economic environment and trade tensions, including the adoption or expansion of economic sanctions, tariffs or trade restrictions,
(xviii) challenges and risks related to sales to government entities and highly regulated organizations, (xix) the impact of competition
and new technologies, (xx) limitations and exclusivity provisions in our customer agreements and restrictions on the use of intellectual
property, (xxi) our ability to ensure that our solutions interoperate with a variety of hardware and software platforms, (xxii) our plans
to continue to invest in research and develop technology for new products, (xxiii) our plans to potentially acquire complementary businesses,
(xxiv) the impact of future pandemics on our business and on the business of our customers, (xxv) fluctuations in foreign currency exchange
rates, (xxvi) security, political and economic instability in the Middle East that could harm our business, including due to the security
situation in Israel; and military conflicts with Iran and terrorist organizations, (xxvii) the increased expenses and requirements associated
with being a listed public company on the Nasdaq Capital Market, or Nasdaq, and (xxviii) risks associated with our dual listing on the
Tel Aviv Stock Exchange, or the TASE, including price volatility, liquidity and regulatory requirements. These and other important factors
discussed in Odysight.ai’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on
March 19, 2026, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the
forward-looking statements made in this press release. Except as required under applicable securities legislation, Odysight.ai undertakes
no obligation to publicly update or revise forward-looking information.
Company
Contact:
Einav
Brenner, CFO
info@odysight.ai
Investor
Relations Contact:
Miri
Segal
MS-IR
LLC
msegal@ms-ir.com
ODYSIGHT.AI
INC.
INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| | |
Nine months ended September 30, | | |
Three months ended September 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Unaudited | |
| | |
USD in thousands | |
| | |
| |
| REVENUES | |
926 | | |
2,576 | | |
424 | | |
149 | |
| COST OF REVENUES | |
| 555 | | |
| 1,882 | | |
| 233 | | |
| 126 | |
| GROSS PROFIT | |
| 371 | | |
| 694 | | |
| 191 | | |
| 23 | |
| RESEARCH AND DEVELOPMENT EXPENSES | |
| 6,979 | | |
| 7,322 | | |
| 2,182 | | |
| 2,479 | |
| SALES AND MARKETING EXPENSES | |
| 2,752 | | |
| 1,604 | | |
| 869 | | |
| 580 | |
| GENERAL AND ADMINISTRATIVE EXPENSES | |
| 4,855 | | |
| 5,473 | | |
| 1,486 | | |
| 1,671 | |
| OPERATING LOSS | |
| (14,215 | ) | |
| (13,705 | ) | |
| (4,346 | ) | |
| (4,707 | ) |
| FINANCING INCOME, NET | |
| 496 | | |
| 949 | | |
| 132 | | |
| 291 | |
| NET LOSS AND COMPREHENSIVE LOSS | |
| (13,719 | ) | |
| (12,756 | ) | |
| (4,214 | ) | |
| (4,416 | ) |
ODYSIGHT.AI
INC.
INTERIM
CONDENSED CONSOLIDATED BALANCE SHEETS
| | |
September 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| | |
Unaudited | | |
| |
| | |
USD in thousands | |
| Assets | |
| | | |
| | |
| | |
| | | |
| | |
| CURRENT ASSETS: | |
| | | |
| | |
| Cash and cash equivalents | |
| 22,815 | | |
| 25,677 | |
| Restricted cash | |
| - | | |
| 333 | |
| Restricted deposit | |
| 337 | | |
| - | |
| Accounts receivable | |
| 470 | | |
| 278 | |
| Unbilled receivables | |
| 757 | | |
| 615 | |
| Inventory | |
| 472 | | |
| 50 | |
| Other current assets | |
| 1,008 | | |
| 549 | |
| Total current assets | |
| 25,859 | | |
| 27,502 | |
| | |
| | | |
| | |
| NON-CURRENT ASSETS: | |
| | | |
| | |
| Property and equipment, net | |
| 189 | | |
| 346 | |
| Operating lease right-of-use assets | |
| 685 | | |
| 739 | |
| Severance pay asset | |
| 309 | | |
| 296 | |
| Other non-current assets | |
| 96 | | |
| 96 | |
| Total non-current assets | |
| 1,279 | | |
| 1,477 | |
| | |
| | | |
| | |
| TOTAL ASSETS | |
| 27,138 | | |
| 28,979 | |
| | |
| | | |
| | |
| Liabilities and shareholders’ equity | |
| | | |
| | |
| | |
| | | |
| | |
| CURRENT LIABILITIES: | |
| | | |
| | |
| Accounts payable | |
| 556 | | |
| 480 | |
| Advances from customers | |
| 95 | | |
| 165 | |
| Operating lease liabilities - short term | |
| 484 | | |
| 511 | |
| Accrued compensation expenses | |
| 1,474 | | |
| 1,400 | |
| Related parties | |
| 107 | | |
| 115 | |
| Other current liabilities | |
| 460 | | |
| 327 | |
| Total current liabilities | |
| 3,176 | | |
| 2,998 | |
| | |
| | | |
| | |
| NON-CURRENT LIABILITIES: | |
| | | |
| | |
| Operating lease liabilities - long term | |
| 189 | | |
| 259 | |
| Liability for severance pay | |
| 309 | | |
| 296 | |
| Total non-current liabilities | |
| 498 | | |
| 555 | |
| | |
| | | |
| | |
| TOTAL LIABILITIES | |
| 3,674 | | |
| 3,553 | |
| | |
| | | |
| | |
| SHAREHOLDERS’ EQUITY: | |
| | | |
| | |
| Common stock, $0.001 par value; 300,000,000 shares authorized as of September 30, 2026 and December 31, 2025, 20,244,405 and 16,357,327 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | |
| 20 | | |
| 17 | |
| Additional paid-in capital | |
| 100,172 | | |
| 88,418 | |
| Accumulated deficit | |
| (76,728 | ) | |
| (63,009 | ) |
| TOTAL SHAREHOLDERS’ EQUITY | |
| 23,464 | | |
| 25,426 | |
| | |
| | | |
| | |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |
| 27,138 | | |
| 28,979 | |